title: Low risk of pancreatitis in HIV-infected patients on hydroxyurea plus didanosine.
authors.forename: P
authors.initials: P
authors.lastname: Barreiro
authors.forename: V
authors.initials: V
authors.lastname: Soriano
authors.forename: E
authors.initials: E
authors.lastname: Valencia
authors.forename: B
authors.initials: B
authors.lastname: Díaz
authors.forename: J
authors.initials: J
authors.lastname: González-Lahoz
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016049:Didanosine / Q000009:adverse effects* / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D015994:Incidence; D010195:Pancreatitis / Q000139:chemically induced / Q000453:epidemiology; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D016049:Didanosine; D006918:Hydroxyurea